Nucleoside phosphonate conjugates as anti HIV agents

Details for Australian Patent Application No. 2005330489 (hide)

Owner Gilead Sciences, Inc.

Inventors Zhang, Lijun; Markevitch, David Y.; Ray, Adrian S.; Petrakovsky, Oleg V.; Mackman, Richard L.; Lin, Kuei-Ying; Boojamra, Constantine G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005330489

PCT Pub. Number WO2006/110157

Priority 60/591,811 27.07.04 US

Filing date 26 July 2005

Wipo publication date 19 October 2006

Acceptance publication date 25 August 2011

International Classifications

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/110157 Priority application(s): WO2006/110157

25 August 2011 Application Accepted

  Published as AU-B-2005330489

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005330494-Artificial dielectrics using nanostructures

2005330479-Patent foramen ovale closure devices, delivery apparatus and related methods and systems